Summit Plc to list on Nasdaq
AIM-listed Summit plc has filed for a proposed offering of American Depositary Shares on the NASDAQ Global Market in the United States.
VastOx Shares – New Shares Raise Company by £10.45M
VASTox, a leading chemical genomics company, has announced that it has successfully raised £10.45 million in a placing of New Ordinary Shares to institutional investors.
VASTox: First Spin-out of 2003
VASTox Ltd, Isis' first spin-out company of 2003, was launched in February from the University of Oxford's Chemistry Department.
Third Phase Limited Merges with Cmed Group
Third Phase Limited, a high-tech company spun out from Oxford University's Department of Engineering Science and now based on the Cambridge Science Park, is pleased to announce that it has merged with the Cmed Group Ltd, opening up tremendous development opportunities for both companies.
Technology Spin-out Management Programme 2009
Start-up and spin-out companies are often on the look out for suitably qualified candidates to take on management roles.
Intelligent Sustainable Energy – Smart meter wins praise
An Oxford University spin-out company, due to launch later this year, has won praise for its smart meter technology from Shadow Chancellor George Osborne.
BioSleep: Demonstrating the Continuum
A paper appearing in EMBC¹ reports a major advance in the study of sleep disorders. Oxford BioSignals, a spin-out company from Oxford University, has developed and validated BioSleep, a novel system based on neural network analysis, which not only elucidates the microstructure of sleep - fleeting changes which have never before been consistently demonstrated - but also reliably detects abnormal sleep patterns.
Oxford Immunotec; Revolutionary new tuberculosis test
A revolutionary new test for identifying people infected with tuberculosis (TB), one of the leading causes of death worldwide, will shortly be launched by Oxford Immunotec Ltd, a new spin-out company from the University of Oxford. The test radically improves the speed and accuracy with which the disease can be identified. It has been developed to replace the existing skin test for TB, which is given to 600,000 UK schoolchildren every year.
Oxonica’s Optisol™ Sunscreen Now Available Boots
Oxonica Ltd, a leading European technology company, has patented a revolutionary new UV filter called Optisol™. As of this month, Optisol™ sunscreen is available on shelves as an active component of Boots' new Soltan Facial Sun Defence Cream.
© Oxford University Innovation